<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2011-15-2-49-56</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-465</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>КЛИНИЧЕСКИЕ, ЛАБОРАТОРНЫЕ И ИНСТРУМЕНТАЛЬНЫЕ ХАРАКТЕРИСТИКИ, АССОЦИИРОВАННЫЕ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ У БОЛЬНЫХ, НАХОДЯЩИХСЯ НА ПРОГРАММНОМ ГЕМОДИАЛИЗЕ</article-title><trans-title-group xml:lang="en"><trans-title>CLINICAL, LABORATORY AND ISTUMENTAL PARAMETERS ASSOCIATED WITH ARTERIAL PRESSURE AT PATIENTS’ ON PROGRAMMED HEMODIALYSIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ЛЯШЕНКО</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>LYASHENKO</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Отделение диализа</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>ГУРЕВИЧ</surname><given-names>К. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>GUREVICH</surname><given-names>K. Ya.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра нефрологии и эфферентной терапии</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>КОРНЕЕВ</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>KORNEEV</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра автоматизированных систем управления</p></bio><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Центральная городская клиническая больница г. Липецка</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Санкт-Петербургская медицинская академия последипломного образования,</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>Липецкий государственный технический университет</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>10</day><month>02</month><year>2011</year></pub-date><volume>15</volume><issue>2</issue><fpage>49</fpage><lpage>56</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; ЛЯШЕНКО О.А., ГУРЕВИЧ К.Я., КОРНЕЕВ А.М., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">ЛЯШЕНКО О.А., ГУРЕВИЧ К.Я., КОРНЕЕВ А.М.</copyright-holder><copyright-holder xml:lang="en">LYASHENKO O.A., GUREVICH K.Y., KORNEEV A.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/465">https://journal.nephrolog.ru/jour/article/view/465</self-uri><abstract/><trans-abstract xml:lang="en"><sec><title>THE AIM</title><p>THE AIM. To study of the data of clinical, laboratory and instrumental parameters associated with arterial hypertension (AH) in the prevalent group of programmed hemodialysis (PHD) patients. PATIENTS AND METHOS. The medical examination was carried out in a prevalent group of patients (n=75) without of cardiovascular insufficiency and who had relatively compensated anemia. They received adequate standard PHD 3 times a week. Their mean arterial pressure (APm) measured 5 minutes before the beginning of a hemodialysis session was more than 107 mmHg. A clinical, laboratory and instrumental examination of the patients was conducted. RESULTS. Among the patients involved in the research 3% had «soft», 54% «moderate» and 43% «grave» AH. It has been ascertained that AH is associated with a shorter dialysis experience (r =-0.21), higher mass of a body index (IMB) (r =0.22), presence of pericardium friction noise (r =0.30), dullness of the percussion sound in iferolateral sections of lung fields (r =0.45), presence of moist rales (r =0.71), worse correction of anemia (r=-0.45), lesser iron reserves (r =-0.37) and lesser international normalized relation (INR) (r =0.37). A higher AP is associated with a higher content of C-reactive protein (CRP) (r =0.37), a atherogenic index (r =0.28), higher values of triglycerides (r =0.29), predialysis plasma sodium (r =0.34), potassium (r =0.43) and phosphorous (r =0.14). In addition to that, a high level of AP is associated with the presence of exudation in the pericardium (r =0.23), a higher left ventriculi mass index (LVMI) (r =0.17), a larger size of the right atrium (r =0.21), a higher pressure in the pulmonary artery ( r =0.34) and a lesser ejection fraction (r =0,32). CONCLUSION. Presented clinical, laboratory and instrumental parameters associated with AH may be of practical value for PHD patients' correction therapy.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>программный гемодиализ</kwd><kwd>артериальная гипертензия</kwd><kwd>кардиомиопатия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>programmed hemodialysis</kwd><kwd>arterial hypertension</kwd><kwd>cardiomyopathy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen E P. Hypertension in chronic hemodialysis: viewing a paradox, and some notes on therapy. Dialys and Transplant 2000; 29: 535-542</mixed-citation><mixed-citation xml:lang="en">Cohen E P. Hypertension in chronic hemodialysis: viewing a paradox, and some notes on therapy. Dialys and Transplant 2000; 29: 535-542</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient's survival. Kidney Int 2000; 58 (5): P 2147-2154</mixed-citation><mixed-citation xml:lang="en">Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient's survival. Kidney Int 2000; 58 (5): P 2147-2154</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Horl M P, Horl WH. Hemodialysis-associated иhypertension: pathophysiology and therapy. Am J Kidney Dis 2002; 39: 227-244</mixed-citation><mixed-citation xml:lang="en">Horl M P, Horl WH. Hemodialysis-associated иhypertension: pathophysiology and therapy. Am J Kidney Dis 2002; 39: 227-244</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Rocco MV, Yan G, Heyka RJ, Benz R et al.; HEMO Study Group. Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO study. Am J Nephrol 2001; 21: 280-288</mixed-citation><mixed-citation xml:lang="en">Rocco MV, Yan G, Heyka RJ, Benz R et al.; HEMO Study Group. Risk factors for hypertension in chronic hemodialysis patients: Baseline data from the HEMO study. Am J Nephrol 2001; 21: 280-288</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277</mixed-citation><mixed-citation xml:lang="en">Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pеrez-Garcia R, Martin-Malo A, Fort J, Cuevas X et al. Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER-a multicentre, prospective, observational cohort study. Nephrol Dial Transplant 2009; 24 (2): 578-588</mixed-citation><mixed-citation xml:lang="en">Pеrez-Garcia R, Martin-Malo A, Fort J, Cuevas X et al. Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER-a multicentre, prospective, observational cohort study. Nephrol Dial Transplant 2009; 24 (2): 578-588</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Бикбов Б Т, Томилина НА. Состояние заместительной почечной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998-2007 г г. (Аналитический отчёт по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2009; 11 (3): 144-233</mixed-citation><mixed-citation xml:lang="en">Бикбов Б Т, Томилина НА. Состояние заместительной почечной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998-2007 г г. (Аналитический отчёт по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2009; 11 (3): 144-233</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Paoletti E, Specchia C, Di Maio G et al. The worsening of the left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10year survey. Nephrol Dial Transplant 2004; 19: 1829-1834</mixed-citation><mixed-citation xml:lang="en">Paoletti E, Specchia C, Di Maio G et al. The worsening of the left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10year survey. Nephrol Dial Transplant 2004; 19: 1829-1834</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Laurent G, Charra B. The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant 1998; 13 (6): 125-131</mixed-citation><mixed-citation xml:lang="en">Laurent G, Charra B. The results of an 8 h thrice weekly haemodialysis schedule. Nephrol Dial Transplant 1998; 13 (6): 125-131</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Добронравов ВА, Боровская ЕА, Владимирова ЮФ, Смирнов АВ. Динамика артериального давления и его суточного профиля у пациентов на стандартном программном гемодиализе: данные двухсуточного мониторирования. Нефрология 2009; 13 (2): 42-49</mixed-citation><mixed-citation xml:lang="en">Добронравов ВА, Боровская ЕА, Владимирова ЮФ, Смирнов АВ. Динамика артериального давления и его суточного профиля у пациентов на стандартном программном гемодиализе: данные двухсуточного мониторирования. Нефрология 2009; 13 (2): 42-49</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Jf Hypertens 1999; 17: 151-185</mixed-citation><mixed-citation xml:lang="en">1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Jf Hypertens 1999; 17: 151-185</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-618</mixed-citation><mixed-citation xml:lang="en">Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-618</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-871</mixed-citation><mixed-citation xml:lang="en">DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-871</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Levy D, Savage DD et al. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-960</mixed-citation><mixed-citation xml:lang="en">Levy D, Savage DD et al. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-960</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Daugirdas J T. Simplified equations for monitoring KT/V, PCRn, eKT/V, and ePCRn. Adv Ren Replace Ther 1995; 2: 295-304.</mixed-citation><mixed-citation xml:lang="en">Daugirdas J T. Simplified equations for monitoring KT/V, PCRn, eKT/V, and ePCRn. Adv Ren Replace Ther 1995; 2: 295-304.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 1999; 14 [Suppl 5]: 50p.</mixed-citation><mixed-citation xml:lang="en">European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 1999; 14 [Suppl 5]: 50p.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Leypoldt JK, Cheung AK, Delmez JA et al. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int 2002; 61: 266-275</mixed-citation><mixed-citation xml:lang="en">Leypoldt JK, Cheung AK, Delmez JA et al. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int 2002; 61: 266-275</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Luik AJ, van Kuijk WHM, Spek J et al. Effects of hypervolemia on interdialytic hemodynamics and blood pressure control in hemodialysis patients. Am J Kidney Dis 1997; 30: 466-474</mixed-citation><mixed-citation xml:lang="en">Luik AJ, van Kuijk WHM, Spek J et al. Effects of hypervolemia on interdialytic hemodynamics and blood pressure control in hemodialysis patients. Am J Kidney Dis 1997; 30: 466-474</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ventura JE, Sposito M. Volume sensitivity of blood pressure in end-stage renal disease. Nephrol Dial Transplant 1997; 12: 485-491</mixed-citation><mixed-citation xml:lang="en">Ventura JE, Sposito M. Volume sensitivity of blood pressure in end-stage renal disease. Nephrol Dial Transplant 1997; 12: 485-491</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wabel P, Moissl U, Chamney PC et al. Towards improved cardiovascular management: the necessity of comorbining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23: 2957-2964</mixed-citation><mixed-citation xml:lang="en">Wabel P, Moissl U, Chamney PC et al. Towards improved cardiovascular management: the necessity of comorbining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23: 2957-2964</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998; 32 (5): 720-724</mixed-citation><mixed-citation xml:lang="en">Charra B, Bergstrom J, Scribner BH. Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998; 32 (5): 720-724</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ozkahya M, Ok E, Toz H et al. Long-term survival rates in haemodialysis patients treated with strict volume control Nephrol Dial Transplant 2006; 21 (12): 3506-3511</mixed-citation><mixed-citation xml:lang="en">Ozkahya M, Ok E, Toz H et al. Long-term survival rates in haemodialysis patients treated with strict volume control Nephrol Dial Transplant 2006; 21 (12): 3506-3511</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal R, Alborzi P, Satyan S et al. Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP). Hypertension 2009; 53: 500</mixed-citation><mixed-citation xml:lang="en">Agarwal R, Alborzi P, Satyan S et al. Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP). Hypertension 2009; 53: 500</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Дудко МЮ, Шутов ЕВ, Капитанов ЕН, Ермоленко ВМ. Влияние нарушений водного баланса на состояние сердечно-сосудистой системы у больных на заместительной почечной терапии. Нефрология и диализ 2006; 8 (3): 244-249</mixed-citation><mixed-citation xml:lang="en">Дудко МЮ, Шутов ЕВ, Капитанов ЕН, Ермоленко ВМ. Влияние нарушений водного баланса на состояние сердечно-сосудистой системы у больных на заместительной почечной терапии. Нефрология и диализ 2006; 8 (3): 244-249</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ibrahim S, Taweel A. Influence of plasma volume status on blood pressure in patients on maintenance hemodialysis. Dialysis and Transplant 2007; 36 (1): 13-24</mixed-citation><mixed-citation xml:lang="en">Ibrahim S, Taweel A. Influence of plasma volume status on blood pressure in patients on maintenance hemodialysis. Dialysis and Transplant 2007; 36 (1): 13-24</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Волгина ГВ. Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недостаточности (обзор литературы). Нефрология и диализ 2000; 2 (1-2): 25-32</mixed-citation><mixed-citation xml:lang="en">Волгина ГВ. Клиническая эпидемиология кардиоваскулярных нарушений при хронической почечной недостаточности (обзор литературы). Нефрология и диализ 2000; 2 (1-2): 25-32</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Волгина ГВ, Перепеченых ЮВ, Бибков БТ и соавт. Факторы риска кардиоваскулярных заболеваний у больных с хронической почечной недостаточностью. Нефрология и диализ 2000; 2 (4): 252-258</mixed-citation><mixed-citation xml:lang="en">Волгина ГВ, Перепеченых ЮВ, Бибков БТ и соавт. Факторы риска кардиоваскулярных заболеваний у больных с хронической почечной недостаточностью. Нефрология и диализ 2000; 2 (4): 252-258</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Basile C, Lomonte C., Vernaglione L. et al. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 282-287</mixed-citation><mixed-citation xml:lang="en">Basile C, Lomonte C., Vernaglione L. et al. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant 2008; 23: 282-287</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">London GM, Guerin A P, Marchais SJ. Hemodynamic overload in the end-stage renal disease patients. Semin Dial 1999; 12: 77-83</mixed-citation><mixed-citation xml:lang="en">London GM, Guerin A P, Marchais SJ. Hemodynamic overload in the end-stage renal disease patients. Semin Dial 1999; 12: 77-83</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kooman J P, Van Der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms. Blood Purif 2004; 22: 55-59</mixed-citation><mixed-citation xml:lang="en">Kooman J P, Van Der Sande FM, Leunissen KM. Role of sodium and volume in the pathogenesis of hypertension in dialysis patients. Reflections on pathophysiological mechanisms. Blood Purif 2004; 22: 55-59</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Santos S F, Peixoto AJ. Hypertension in dialysis. Curr Opin Nephrol Hypertens 2005; 14: 111-118</mixed-citation><mixed-citation xml:lang="en">Santos S F, Peixoto AJ. Hypertension in dialysis. Curr Opin Nephrol Hypertens 2005; 14: 111-118</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal R. Management of hypertension in hemodialysis patients. Hemodial Int 2006; 10: 241-248</mixed-citation><mixed-citation xml:lang="en">Agarwal R. Management of hypertension in hemodialysis patients. Hemodial Int 2006; 10: 241-248</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Tomson ChRV, Shresha SM. The pivotal role of sodium balance in control of blood pressure in dialysis patients. Hemodialysis International 2007; 11 [Suppl 2]: S21 -S26</mixed-citation><mixed-citation xml:lang="en">Tomson ChRV, Shresha SM. The pivotal role of sodium balance in control of blood pressure in dialysis patients. Hemodialysis International 2007; 11 [Suppl 2]: S21 -S26</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kooman J P, Van Der Sande FM, Leunissen KM. Sodium, blood pressure and cardiovascular pathology: is it all volaemia? Nephrol Dial Transplant 2004; 19: 1049-1049</mixed-citation><mixed-citation xml:lang="en">Kooman J P, Van Der Sande FM, Leunissen KM. Sodium, blood pressure and cardiovascular pathology: is it all volaemia? Nephrol Dial Transplant 2004; 19: 1049-1049</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int 2004; 66: 2454-2466</mixed-citation><mixed-citation xml:lang="en">de Wardener HE, He FJ, MacGregor GA. Plasma sodium and hypertension. Kidney Int 2004; 66: 2454-2466</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">He FJ, Markandu ND, Sagnella GA et al. Plasma sodium: ignored and underestimated. Hypertension 2005; 45: 98-102</mixed-citation><mixed-citation xml:lang="en">He FJ, Markandu ND, Sagnella GA et al. Plasma sodium: ignored and underestimated. Hypertension 2005; 45: 98-102</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ермоленко ВМ. Хроническая почечная недостаточность. В: Тареева ИЕ, ред. Нефрология. Руководство для врачей. Медицина, М., 2000; 596 -644</mixed-citation><mixed-citation xml:lang="en">Ермоленко ВМ. Хроническая почечная недостаточность. В: Тареева ИЕ, ред. Нефрология. Руководство для врачей. Медицина, М., 2000; 596 -644</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Block GA, Hulbert-Shearon TE, Levin NW. et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617</mixed-citation><mixed-citation xml:lang="en">Block GA, Hulbert-Shearon TE, Levin NW. et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Huang CX, Plantinga LC, Fink NE et al. Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal study. Adv Chronic Kidney Dis 2008; 15 (3): 321-331.</mixed-citation><mixed-citation xml:lang="en">Huang CX, Plantinga LC, Fink NE et al. Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal study. Adv Chronic Kidney Dis 2008; 15 (3): 321-331.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126</mixed-citation><mixed-citation xml:lang="en">Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Triperi G, Mallamaci F, Zoccali C. Inflammantion markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005; 16 [Suppl 1]: 83-88</mixed-citation><mixed-citation xml:lang="en">Triperi G, Mallamaci F, Zoccali C. Inflammantion markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005; 16 [Suppl 1]: 83-88</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Wanner C, Zimmermann J, Schwelder S. et al. Inflammantion and cardiovascular risk in dialysis patients. Kidney Int 2002; S80: 99-102</mixed-citation><mixed-citation xml:lang="en">Wanner C, Zimmermann J, Schwelder S. et al. Inflammantion and cardiovascular risk in dialysis patients. Kidney Int 2002; S80: 99-102</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Honda H, Qureshi A, Heimburger O. et al. Serum albumin, C-reative protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148</mixed-citation><mixed-citation xml:lang="en">Honda H, Qureshi A, Heimburger O. et al. Serum albumin, C-reative protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006; 47: 139-148</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">London GM. Pathophysisology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 2001; 16 (2): 3-6</mixed-citation><mixed-citation xml:lang="en">London GM. Pathophysisology of cardiovascular damage in the early renal population. Nephrol Dial Transplant 2001; 16 (2): 3-6</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Cooke J P. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037</mixed-citation><mixed-citation xml:lang="en">Cooke J P. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">U.S. Renal Data System, USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diadetes and Digestive and Kidney Diseases, Bethesda, MD, 2003: 560</mixed-citation><mixed-citation xml:lang="en">U.S. Renal Data System, USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diadetes and Digestive and Kidney Diseases, Bethesda, MD, 2003: 560</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Harrison DG. Cellular and molecular mechanisms of endothelial dysfunction? J Clin Invest 1997; 100: 2153-2157</mixed-citation><mixed-citation xml:lang="en">Harrison DG. Cellular and molecular mechanisms of endothelial dysfunction? J Clin Invest 1997; 100: 2153-2157</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
